Brief: Active Biotech Q1 Operating Loss Narrows To SEK 9.7 Million
April 23 (Reuters) - Active Biotech AB ACTI.ST :
* REG-ACTIVE BIOTECH INTERIM REPORT JANUARY - MARCH 2020
* Q1 OPERATING LOSS SEK 9.7 MILLION VERSUS LOSS SEK 6.4
MILLION
YEAR AGO
Source text for Eikon: ID:nGNE3Kh1Kx
Further company coverage: ACTI.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))